Back to Search Start Over

Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?

Authors :
Ndjeka N
Conradie F
Meintjes G
Reuter A
Hughes J
Padanilam X
Ismail N
Kock Y
Master I
Romero R
Te Riele J
Enwerem M
Ferreira H
Maartens G
Source :
The European respiratory journal [Eur Respir J] 2020 Jul 23; Vol. 56 (1). Date of Electronic Publication: 2020 Jul 23 (Print Publication: 2020).
Publication Year :
2020

Abstract

Competing Interests: Conflict of interest: N. Ndjeka has nothing to disclose. Conflict of interest: F. Conradie has nothing to disclose. Conflict of interest: G. Meintjes has nothing to disclose. Conflict of interest: A. Reuter has nothing to disclose. Conflict of interest: J. Hughes has nothing to disclose. Conflict of interest: X. Padanilam has nothing to disclose. Conflict of interest: N. Ismail has nothing to disclose. Conflict of interest: Y. Kock has nothing to disclose. Conflict of interest: I. Master has nothing to disclose. Conflict of interest: R. Romero has nothing to disclose. Conflict of interest: J. te Riele has nothing to disclose. Conflict of interest: M. Enwerem has nothing to disclose. Conflict of interest: H. Ferreira has nothing to disclose. Conflict of interest: G. Maartens has nothing to disclose.

Details

Language :
English
ISSN :
1399-3003
Volume :
56
Issue :
1
Database :
MEDLINE
Journal :
The European respiratory journal
Publication Type :
Editorial & Opinion
Accession number :
32471936
Full Text :
https://doi.org/10.1183/13993003.01369-2020